Related Experiment Video
Updated: Jun 6, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
31.9K
Breathing Easy During Training. Strategies for Managing Exercise-Induced Bronchoconstriction
Santiago Cruz Arce1, Rosaura Esperanza Benítez-Pérez2
1Medical Research Institute, A. Lanari, University of Buenos Aires, Combatientes de Malvinas 3150 (1427), Buenos Aires, Argentina.
Immunology and Allergy Clinics of North America
|November 28, 2024
Summary
Managing exercise-induced asthma (EIA) and bronchoconstriction (EIB) requires adherence to asthma guidelines and prompt use of short-acting beta-agonists. Tailored treatment plans are crucial, especially for children and athletes, to manage symptoms and ensure optimal performance.
Area of Science:
- Pulmonology
- Sports Medicine
- Pediatrics
Background:
- Exercise-induced asthma (EIA) and exercise-induced bronchoconstriction (EIB) present diagnostic challenges.
- Asthmatic patients require baseline treatment following established asthma guidelines.
- Short-acting beta-agonists are the primary pharmacotherapy for symptom management.
Purpose of the Study:
- To provide critical insights into managing exercise-induced respiratory issues in asthmatic individuals.
- To highlight the complexities in differentiating EIA and EIB.
- To emphasize tailored management strategies for diverse patient populations.
Main Methods:
- Review of current asthma management guidelines.
- Assessment of treatment efficacy through symptom remission.
- Consideration of specialized and serial testing for athletes.
Main Results:
- EIA and EIB necessitate careful differentiation and management.
- Baseline treatment with short-acting beta-agonists is key.
- Environmental trigger avoidance is essential for symptom control.
Conclusions:
- Effective management requires individualized approaches for asthmatic patients, particularly children and athletes.
- Physician assessment of treatment efficacy is vital for symptom remission.
- Optimizing treatment plans ensures athletes can maintain peak performance.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
179
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179
01:17Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Asthma: Pathogenesis and Management
351
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351